Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Bowerman

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Human Molecular Genetics|November 10, 2023
A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) modelsJoseph M Hoolachan, Eve McCallion, Emma R Sutton, et al.
Skeletal Muscle|October 13, 2024
Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1<sup>G93A</sup> amyotrophic lateral sclerosis (ALS) mouse modelGareth Hazell, Eve McCallion, Nina Ahlskog, et al.
Skeletal Muscle|July 28, 2022
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy miceKatharina E Meijboom, Emma R Sutton, Eve McCallion, et al.
Scientific Reports|November 17, 2025
Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn<sup>2B/-</sup> spinal muscular atrophy miceEmma R Sutton, Eve McCallion, Joseph M Hoolachan, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Abnormal fatty acid metabolism is a core component of spinal muscular atrophyMarc-Olivier Deguise, Giovanni Baranello, Chiara Mastella, et al.
Ebiomedicine|May 9, 2018
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy MiceLisa M Walter, Marc-Olivier Deguise, Katharina E Meijboom, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Human Molecular Genetics|November 10, 2023
A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) modelsJoseph M Hoolachan, Eve McCallion, Emma R Sutton, et al.
Skeletal Muscle|October 13, 2024
Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1<sup>G93A</sup> amyotrophic lateral sclerosis (ALS) mouse modelGareth Hazell, Eve McCallion, Nina Ahlskog, et al.
Skeletal Muscle|July 28, 2022
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy miceKatharina E Meijboom, Emma R Sutton, Eve McCallion, et al.
Scientific Reports|November 17, 2025
Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn<sup>2B/-</sup> spinal muscular atrophy miceEmma R Sutton, Eve McCallion, Joseph M Hoolachan, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Abnormal fatty acid metabolism is a core component of spinal muscular atrophyMarc-Olivier Deguise, Giovanni Baranello, Chiara Mastella, et al.
Ebiomedicine|May 9, 2018
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy MiceLisa M Walter, Marc-Olivier Deguise, Katharina E Meijboom, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 4